IL93304A - Method for production and purification of hepatitis b vaccine - Google Patents

Method for production and purification of hepatitis b vaccine

Info

Publication number
IL93304A
IL93304A IL93304A IL9330490A IL93304A IL 93304 A IL93304 A IL 93304A IL 93304 A IL93304 A IL 93304A IL 9330490 A IL9330490 A IL 9330490A IL 93304 A IL93304 A IL 93304A
Authority
IL
Israel
Prior art keywords
molecular weight
hepatitis
high molecular
purification
contaminant proteins
Prior art date
Application number
IL93304A
Other languages
English (en)
Other versions
IL93304A0 (en
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of IL93304A0 publication Critical patent/IL93304A0/xx
Publication of IL93304A publication Critical patent/IL93304A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL93304A 1989-02-07 1990-02-07 Method for production and purification of hepatitis b vaccine IL93304A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30777789A 1989-02-07 1989-02-07

Publications (2)

Publication Number Publication Date
IL93304A0 IL93304A0 (en) 1990-11-29
IL93304A true IL93304A (en) 1992-09-06

Family

ID=23191134

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93304A IL93304A (en) 1989-02-07 1990-02-07 Method for production and purification of hepatitis b vaccine

Country Status (13)

Country Link
EP (1) EP0408742B1 (ru)
JP (1) JP2825647B2 (ru)
KR (1) KR0148119B1 (ru)
AT (1) ATE112170T1 (ru)
AU (1) AU632575B2 (ru)
CA (1) CA2026570C (ru)
DE (1) DE69012903T2 (ru)
DK (1) DK0408742T3 (ru)
ES (1) ES2061040T3 (ru)
HK (1) HK183395A (ru)
IL (1) IL93304A (ru)
RU (1) RU2080876C1 (ru)
WO (1) WO1990010058A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
CN103319572B (zh) * 2012-03-20 2015-06-24 北京天坛生物制品股份有限公司 一种乙型肝炎表面抗原的纯化方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4741901A (en) * 1981-12-03 1988-05-03 Genentech, Inc. Preparation of polypeptides in vertebrate cell culture
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
FI861417A0 (fi) * 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
IL79740A0 (en) * 1986-08-17 1986-11-30 Yeda Res & Dev Hepatitis vaccine
AU1391888A (en) * 1987-02-11 1988-09-14 Scripps Clinic And Research Foundation Retroviral expression vectors and methods for producing hbv antigens
JPS63230639A (ja) * 1987-03-19 1988-09-27 Nippon Chem Res Kk 新規なｂ型肝炎ウイルス表面抗原粒子とその製法
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
EP0328123A1 (en) * 1988-02-09 1989-08-16 Eugene Tech International, Inc. Heterogeneous, pre-S rich hepatitis B surface antigen

Also Published As

Publication number Publication date
CA2026570C (en) 2000-05-30
JPH03503847A (ja) 1991-08-29
HK183395A (en) 1995-12-08
AU632575B2 (en) 1993-01-07
DE69012903T2 (de) 1995-05-11
KR0148119B1 (ko) 1998-08-17
CA2026570A1 (en) 1991-01-08
EP0408742B1 (en) 1994-09-28
IL93304A0 (en) 1990-11-29
EP0408742A4 (en) 1992-12-09
ATE112170T1 (de) 1994-10-15
RU2080876C1 (ru) 1997-06-10
DE69012903D1 (de) 1994-11-03
DK0408742T3 (da) 1995-03-20
ES2061040T3 (es) 1994-12-01
EP0408742A1 (en) 1991-01-23
WO1990010058A3 (en) 1990-11-01
AU5648590A (en) 1990-09-26
WO1990010058A2 (en) 1990-09-07
KR910700071A (ko) 1991-03-13
JP2825647B2 (ja) 1998-11-18

Similar Documents

Publication Publication Date Title
ATE206311T1 (de) Verfahren zur herstellung von virusimpfstoff aus abgeschwächten varicella zoster viren
DE69626022D1 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
EP0317810A3 (de) Verfahren und Vorrichtung zum Ablösen von Zellkulturen von Mikroträgern
EP0231083A3 (en) Purification of pertussis antigens
IL93304A (en) Method for production and purification of hepatitis b vaccine
AU648281B2 (en) Methods for the biological inactivation of nucleic acids
FR2510606B1 (ru)
WO1998036636A3 (en) Method for generating embryogenic cell cultures for the production of bananas (musa spp.)
ATE132875T1 (de) Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung
EP0295605B1 (en) Antibody production-stimulating factor derived from human B lymphoblastoid cell and process for producing antibody by using said stimulating factor
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
ES2094695A1 (es) Nueva cepa de haloferax gibbonsii, halocina h7 producida por ella y procedimiento de obtencion de ambas.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
PEL Intention of commissioner to extend period of protection
EXTG Extension of patent term granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
MM9K Patent not in force due to non-payment of renewal fees